Results 81 to 90 of about 6,506,258 (188)
Bruton tyrosine kinase inhibitors and cardiovascular adverse events
Abstract Bruton tyrosine kinase inhibitors (BTKi) have transformed the management of chronic lymphocytic leukaemia and other B‐cell malignancies, yet their therapeutic benefit is tempered by clinically relevant cardiovascular toxicities (predominantly atrial fibrillation, hypertension, bleeding and ventricular arrhythmias).
Massimiliano Camilli +4 more
wiley +1 more source
Mantle cell lymphoma shows a peculiar immunogenetic profile, but the functional consequences of this fact are unknown. We have determined the precise sequences of rearranged heavy and light chain genes in several mantle cell lymphoma cell lines and ...
ZAMO', Alberto +7 more
core +1 more source
Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient [PDF]
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy.
Raoufi, Mohammad +6 more
core +1 more source
A rare case of breast carcinoma co-existing with axillary mantle cell lymphoma
Background Mantle cell lymphoma (MCL) is a rare variety of non-Hodgkin's lymphoma which originates from CD5+ B-cell population in the mantle zones of lymphoid follicles. Coexistence of such tumours in the axillary lymph nodes with invasive breast cancers
Scally John +3 more
doaj +1 more source
BTK inhibition reprograms macrophages to suppress IL‐6/IL‐8/IL‐10‐driven CRS without compromising BsAb efficacy. ABSTRACT Bispecific antibodies (BsAbs) have shown marked efficacy in relapsed or refractory (R/R) B‐cell non‐Hodgkin lymphoma (B‐NHL). However, their clinical utility is constrained by cytokine release syndrome (CRS).
Jiaowu Cao +8 more
wiley +1 more source
Management of mantle cell lymphoma in the elderly patient
Jeanette K Doorduijn,1 Hanneke C Kluin-Nelemans2 1Department of Hematology, Erasmus MC, Rotterdam, The Netherlands; 2Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands Abstract: Mantle cell
Doorduijn JK, Kluin-Nelemans HC
core
Mantle Cell Lymphoma: State of the Art
: Mantle cell lymphoma (MCL) accounts for ...
MD Andre H Goy, MD Alan P Skarbnik
core
Non-polypoidal, synchronous mantle- cell lymphoma of small intestine: a rare case
Herein is reported the case of a mantle cell lymphoma (MCL) with synchronous double intestinal location. A 74 - year old male presented with mild abdominal pain.
Sikalias Nikolaos +5 more
doaj +1 more source
ABSTRACT Aberrant expression of T‐cell markers in B‐cell lymphomas is rare and can pose diagnostic challenges. We report a case of a 65‐year‐old man presenting with newly developed scalp nodules. Histopathology revealed nodular lymphoid infiltrates composed of large centrocytes and centroblasts.
V. Pfefferle +4 more
wiley +1 more source
Emerging role of SOX11 in mantle cell lymphoma
Venera Kuci,1,2,* Lena Nordström,1,2,* Mats Jerkeman,3 Sara Ek1,2 1Department of Immunotechnology, Lund University, Lund, Sweden; 2CREATE Health, Lund University, Lund, Sweden; 3Department of Oncology, Lund University, Lund, Sweden *These authors ...
Jerkeman M, Ek S, Kuci V, Nordström L
core

